Top 10 AI Tools for Doctors

Purpose-built AI clinical assistant that generates structured medical notes from doctor-patient conversations with HIPAA compliance, but limited to documentation rather than clinical decision support.

Strong EHR integration across 150+ health systems and 35+ languages with meaningful clinician efficiency gains, but hallucination complaints and cluttered interface concerns, plus opaque pricing, limit the score.

Free tier lacks BAA creating HIPAA risk for PHI-handling practices, training data use ambiguous in publicly unavailable enterprise agreements, and no third-party security certifications confirmed despite healthcare context requiring them.

Impressive adoption with 85,000+ clinicians and 20M+ patient encounters annually across 130+ health organizations, major health system wins in 2026, and a high-profile AI partnership with AMI/Yann LeCun signal strong market traction.

Well-documented Core API with OAuth 2.0 and Postman collection, active 2026 product launches including on-device Mac dictation, but deprecated Care Platform SDKs and absence of active multi-language SDKs limit developer experience depth.

AI search engine for peer-reviewed medical research that extracts evidence-based findings doctors need for clinical decision-making, but not designed exclusively for medical use cases.

Consensus earns strong marks for core utility with 4.7/5 across 1,657 G2 reviews confirming intuitive UX and solid search across 220M+ papers, though creation/editing tools lag and pricing restrictiveness noted by users drags ROI accessibility slightly.

Privacy and security posture is underdocumented in available evidence — no SOC 2 or explicit training opt-out confirmed — though no known breaches or incidents exist and the $30M raise with credible investors adds stability confidence.

Strong adoption signals with millions of monthly API users, $30M raise in May 2026 from recognizable VCs including Union Square Ventures, ChatGPT App listing, and active G2 review growth all point to a healthy market position.

V2 API with code samples in JS, Python, and Go, MCP server for Claude/ChatGPT/Cursor integration, and GitHub-hosted API repo demonstrate solid developer maturity, though versioning details and rate limit documentation have minor gaps.

AI voice assistant specifically built for doctors to generate clinical notes from patient conversations with medical terminology optimization, though slightly less established than Nabla in structured note output.

Suki delivers strong ambient note generation validated by KLAS 93.8/100 and 95% would-buy-again rate, with deep Epic, Oracle Health, athenahealth, and MEDITECH integrations, but high pricing ($299–$399+/month with setup fees, no free tier) and complaints about generic notes and missed medication names constrain the operational score.

HIPAA compliance and SOC 2 Type II certification are confirmed, Google Cloud Vertex AI partnership adds credibility, and BAA availability is standard; no known data breaches or major incidents were identified, though hallucination of medication names is a documented concern.

Suki demonstrates exceptional market traction with 4x growth in 2024 followed by tripling in 2025, $168M raised at ~$500M valuation with a 2024 Series D, 400+ health system partnerships, Epic Toolbox membership, and a Zoom partnership covering 140,000 healthcare organizations globally.

Suki for Partners provides REST APIs, Web SDK, Mobile SDK, and Headless SDK launched June 2024 with developer docs updated July 2026, but access is credentialed rather than self-service, GitHub activity is limited to a third-party API evangelist repo, and orchestration/webhook documentation appears incomplete.

Knowledge management system that helps doctors organize clinical notes and medical research with powerful linking, but requires significant setup and lacks medical-specific templates.

Obsidian's core note-linking and knowledge management capability is well-validated by 22k+ reviews averaging 4.5–4.7/5, with strong ROI via a fully free core app, but meaningful learning curve (3+ weeks for some users, requires Markdown fluency) and fragmented AI via third-party plugins rather than native features pull the score below top tier.

Plain-text local storage with no forced cloud sync is a strong privacy posture, but no SOC 2 or security certifications were found, no public status page was confirmed, and the company (Dynalist Inc.) is bootstrapped with no disclosed third-party security audits, limiting the ceiling.

~1.5 million users and ~$25M ARR as of April 2026 with 1,600+ community plugins signals strong organic adoption velocity, but the bootstrapped funding model (no VC raise data), absence of major enterprise marketplace listings, and niche positioning cap the market score.

Active GitHub development with releases through August 2026, a TypeScript plugin API with documented sample templates, and ESLint CI pipelines show solid developer hygiene, but no versioned REST API, no official SDKs for Python/JS beyond plugin TypeScript definitions, no webhooks, and no SLA documentation keep infrastructure scores moderate.

General AI assistant excellent at explaining complex medical concepts and drafting patient communications with safety features, but not purpose-built for clinical workflows or documentation.

G2 4.6/5 across 476 reviews with consistent praise for coding, documentation, and analysis; usage limit complaints are the primary friction but do not block core utility, and free tier plus $20/mo Pro makes it highly accessible.

Privacy posture and SOC 2 certification not explicitly confirmed in evidence, creating gaps; however, hallucination rate praised as lower than ChatGPT/Gemini across multiple sources and Anthropic's safety-first reputation is well established.

Claude Marketplace launched March 2026, $100M Partner Network announced, Sonnet 5.5 expanded across major cloud platforms, and 476 G2 reviews with active growth signal strong and accelerating ecosystem adoption.

Seven official SDKs, Claude Code repo at 149k GitHub stars with 5,000+ monthly commits, versioned API with prompt caching, streaming, webhooks, Dynamic Workflows for parallel subagents, and LangChain-compatible architecture represent best-in-class developer infrastructure.

Free AI meeting recorder that summarizes telemedicine calls and automates note-taking for virtual consultations, but lacks medical terminology optimization and clinical structure.

Fathom delivers exceptional core task utility with near-perfect G2 ratings across 6,600 reviews, strong CRM integrations with HubSpot and Salesforce, and reliable 30-second post-meeting summaries, though free-tier AI summaries were capped at 5/month as of June 2026, reducing ROI accessibility slightly.

Privacy posture is adequate with GDPR signals but no confirmed SOC 2 Type II, no explicit HIPAA compliance or BAA availability, and training data opt-out status is ambiguous, creating meaningful gaps for regulated industries.

Fathom shows exceptional adoption velocity with 6,600 G2 reviews and a 5.0 rating, $61M total funding with a May 2026 undisclosed round from Google Ventures, though it skews heavily toward SMB (78% small business) limiting enterprise ecosystem signals.

Developer docs at developers.fathom.ai confirm REST API, webhook support, and TypeScript/Python SDKs, but GitHub activity is limited, changelog last updated February 2026, and rate limits and OpenAPI spec availability are not confirmed.

AI research assistant that finds and summarizes academic papers useful for staying current with medical literature, though generalist design means it lacks medical-specific extraction features.

Elicit reliably searches 138M+ verified academic papers with strong praise for avoiding hallucinated studies, meaningful free tier and affordable Plus plan, but paywalled content limits full-text extraction and G2 review presence is absent with very thin third-party review volume overall.

SOC 2 compliance confirmed as of August 2025 is a positive trust signal, but training data opt-out posture and GDPR DPA availability are unconfirmed in evidence, and no additional certifications (ISO 27001, HIPAA) were found.

Elicit shows consistent product velocity with near-weekly feature launches since 2021 and a Team Plan added February 2025, but no funding round data was found and G2/Capterra review volume is extremely thin (1 Capterra review), limiting adoption velocity scoring.

API v2 is documented with Python, JavaScript, and curl examples, MCP server support confirmed as of July 2026, and async report polling is functional, though rate limits and OpenAPI spec availability were not confirmed in evidence.

AI search engine that provides cited medical information useful for quick clinical queries, but lacks specialized medical database access and peer-review filtering that doctors require.

G2 rating of 4.4/5 across 326 reviews with 95% ease-of-use scores, robust free tier with cited real-time search, and broad model selection on Pro confirm strong core utility, though complaints about slow responses and limitations in complex reasoning vs ChatGPT/Claude cap the score.

Enterprise Pro explicitly guarantees no training on user data and includes SSO/audit logs, but security certifications beyond enterprise claims are not documented in evidence, training data handling for free users is ambiguous, and customer support responsiveness draws heavy criticism on Trustpilot.

ARR growth from ~$232M to ~$750M in under a year, 300+ publisher revenue-sharing program, Microsoft Azure $750M deal, US federal procurement approval, and Snapchat integration signal exceptional adoption velocity and ecosystem momentum.

Official Python and Node.js SDKs with versioned API (v1), MCP documentation server, OpenAI-compatible endpoint, Agent/Search/Embeddings API trio, and LangChain/LlamaIndex compatibility confirm strong developer infrastructure, though no explicit SLA or status page history was surfaced in evidence.

General-purpose AI useful for drafting patient communications and explaining medical concepts, but not HIPAA-compliant and lacks clinical documentation features doctors need.

G2 4.7/5 from 2,000+ reviews with 96% ease-of-use satisfaction confirms exceptional core utility, but hallucination complaints (107 G2 mentions, 75% of professionals reporting hallucinations) and output reliability issues prevent a higher score.

OpenAI has enterprise-grade security and GDPR compliance, but persistent hallucination complaints across 75% of professionals, ambiguous training data opt-out posture for free users, and the lack of confirmed SOC 2 Type II details in the evidence temper the trust score.

900 million weekly active users, 50 million paying subscribers, 7 pricing tiers, and dominant tier-1 press coverage make ChatGPT the unambiguous market leader with no meaningful adoption velocity concerns.

Official SDKs for Python, Node.js, .NET, versioned API with full documentation, Agents SDK for orchestration, LangChain/LlamaIndex compatibility, and active DevDay (Sept 2026) expansions demonstrate mature, actively developed infrastructure.

Flexible workspace with AI writing features useful for medical practice management and patient resources, but generalist design means no HIPAA compliance or clinical optimization.

Notion AI scores well on core utility (4.7/5 G2 across 4,000+ reviews, praised for knowledge consolidation) but is dinged by consistent complaints of AI slowness, latency on large pages, clunky mobile, and weak email/calendar integration that limits workflow depth.

Notion has a public status page and GDPR mentions, but evidence on SOC 2 certification, explicit AI training opt-out, and data handling policy clarity was not surfaced in the research, capping trust confidence and score.

With $11B valuation, 100M+ users, 4,000+ G2 reviews, active product velocity (Workers for Agents, Skills, April 2026 feature drop), and strong product-led growth signals, Notion AI demonstrates exceptional market adoption and ecosystem strength.

Notion offers official SDKs in JavaScript, Python, Go, C#, JVM, and PHP with versioned API (2026-03-11), active GitHub ecosystem, and a public developer docs site, though Workers for Agents remains in developer preview with execution constraints limiting full orchestration readiness.